SP100 expression was reported in 11 studies across cancers, including HCC, lung cancer, breast cancer, PAAD, glioma, mantle cell lymphoma, laryngeal cancer, CRC, and ccRCC. Here, SP100 is linked to nonpapillary renal cell carcinoma.